Indicated for: pain and inflammation
Route of administration: rectal
Substance: morniflumat (analgesic and antipyretic)
ATC: M01AX22 (Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Other antiinflammatory and antirheumatic agents, non-steroids)
Morniflumate is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation associated with musculoskeletal conditions such as arthritis or sprains. It works by inhibiting prostaglandin synthesis, reducing inflammation and pain.
The medication is taken orally, usually in tablet form, and is indicated for short-term use. It is effective in relieving symptoms and improving mobility.
Side effects may include nausea, dyspepsia, abdominal pain, or, in rare cases, gastric ulcers or allergic reactions. It is important to follow the recommended dosage and avoid prolonged use without medical supervision.
Consult your doctor before use, especially if you have gastrointestinal conditions or are taking other medications. Use Morniflumate as directed to avoid complications.